A powerful oral triplet for AL amyloidosis

Br J Haematol. 2020 May;189(4):605-606. doi: 10.1111/bjh.16471. Epub 2020 Feb 3.

Authors

Giovanni Palladini¹, Paolo Milani¹, Giampaolo Merlini¹

Affiliation

¹ Amyloidosis Research and Treatment Center, Foundation "Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo", Department of Molecular Medicine, University of Pavia, Pavia, Italy.

PMID: 32011727
DOI: 10.1111/bjh.16471

No abstract available

Keywords: AL amyloidosis; circulating amyloidogenic light chain; plasma cell targeting agents.

MeSH terms

Administration, Oral
Humans
Immunoglobulin Light-chain Amyloidosis / drug therapy*